ABVX

$

(%)

Exchange:
Market Cap:
Shares Outstanding:

About The Company

Click to read more…

Revenue Segmentation

🔒 You are currently logged out

It’s free

EPS

🔒 You are currently logged out

It’s free

View full analyst estimates

Earnings Call

🔒 You are currently logged out

It’s free

Income Statement

Balance Sheet

Cash Flow Statement

Analyst Estimates

Income Statement

(* All numbers are in thousands)

🔒 You are currently logged out

It’s free

Balance Sheet

(* All numbers are in thousands)

🔒 You are currently logged out

It’s free

Cash Flow Statement

(* All numbers are in thousands)

🔒 You are currently logged out

It’s free

Analyst Estimates

(* All numbers are in thousands)

🔒 You are currently logged out

It’s free

Current Key Metrics

🔒 You are currently logged out

It’s free

Forward P/E Ratios

🔒 You are currently logged out

It’s free

SWOT Analysis

🔒 You are currently logged out

It’s free

At what price to buy it? –
Intrinsic Value Calculator

Calculate ABVX Intrinsic Value

🔒 You are currently logged out

It’s free

Relevant news

13-11-2025 13:01

Abivax SA Sponsored ADR (ABVX) Upgraded to Buy: Here’s What You Should Know

14-10-2025 08:41

Abivax: Betting Big On The Next Inflammatory Bowel Disease Blockbuster

06-10-2025 12:35

ABIVAX Société Anonyme (ABVX) Shareholder/Analyst Call Transcript

29-09-2025 16:05

Abivax Announces Acceptance of Additional Late-Breaking Abstract from the ABTECT Phase 3 Induction Trials to be Presented at 2025 United European Gastroenterology (UEG) Meeting

23-09-2025 16:05

Abivax Announces Presentation of Late-Breaking Abstract for Obefazimod from the ABTECT Phase 3 Induction Trials at 2025 United European Gastroenterology (UEG) Meeting